Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Inhalation of 4% and 67% hydrogen ameliorates oxidative stress, inflammation, apoptosis, and necroptosis in a rat model of glycerol-induced acute kidney injury.

Jun-Li Xue, Bo-Yan Liu, Min Zhao, Meng-Yu Zhang, Ming-Yue Wang, Qian-Qian Gu, Xiao-Yi Zhang, Shu-Cun Qin · Medical gas research · 2023

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Inflammation and Immune Regulation
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In rats, however, higher concentration of H₂ inhalation improved histological and morphological changes better. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. However, higher concentration of H₂ inhalation improved histological and morphological changes better.

What the Researchers Studied

The researchers studied rats. The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

Recently, numerous studies have reported the therapeutic effects of molecular hydrogen (H₂) on oxidative stress and inflammation-related diseases. Here, the effects of H₂ against glycerol-induced AKI and the underlying mechanisms were explored in rats. Low (4%) and high (67%) concentrations of H₂ were prepared using a self-made device to investigate the dose-response. However, higher concentration of H₂ inhalation improved histological and morphological changes better. The authors concluded that this study suggests that H₂ is a potential alternative therapy to prevent or minimize RM induced AKI possibly via its antioxidant, anti-inflammatory, anti-apoptotic and anti-necroptotic properties.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.